AssetMark Inc’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

AssetMark Inc’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-29	Closed	-$1K	–	2100
2017 Q4	$1K	Buy	+29	New	+$525	﹤0.01%	1764

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AssetMark Inc's SPPI Position: Q1 2018 in Review

AssetMark Inc sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2018, closing a stake of 29 shares — an estimated $1K sold.

AssetMark Inc first reported a position in SPPI in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 161 funds tracked by Wall St. Rank hold SPPI as of Q1 2018.

AssetMark Inc reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2018 after selling out during the quarter.
AssetMark Inc sold 29 Spectrum Pharmaceuticals Inc shares in Q1 2018, an estimated $1K.
AssetMark Inc first reported a position in Spectrum Pharmaceuticals Inc in Q4 2017 and held it in 1 quarter.
AssetMark Inc's Spectrum Pharmaceuticals Inc position peaked at $1K in Q4 2017.
161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2018.

Based on AssetMark Inc's 13F filing for Q1 2018, filed 16 May 2018.